May 15 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2026 Mar 31, 2025 Dec 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 5 mln 2 mln 507 mln
(+158.9 pct) (+296.4 pct)
Operating loss 246 mln loss 419 mln loss 1.47
Recurring loss 244 mln loss 422 mln loss 1.47
Net loss 238 mln loss 429 mln loss 1.50
EPS loss 4.02 yen loss 9.04 yen loss 25.30 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Medrx.Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T